Rare Glycogen Storage Diseases Natural History Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-12-23

Study Completion Date

2034-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to collect and study key medical data about several ultra-rare GSDs (Glycogen Storage Diseases) including, but not limited to, GSD types 0a, 0b, VII, X, XII, XIII, XV, PRKAG2 syndrome and Danon disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of Glycogen Storage Disease Expression in Carriers

NCT02057731

Glycogen Storage Disease

COMPLETED

Study of Glycogen Storage Disease and Associated Disorders

NCT00001342

Glycogen Storage Disease

COMPLETED

Rare and Undiagnosed Disease Research Biorepository

NCT04703179

Undiagnosed Disease Rare Diseases

ENROLLING_BY_INVITATION

Natural History of Glycosphingolipid Storage Disorders and Glycoprotein Disorders

NCT00029965

Neurological Regression Myoclonus Cherry Red Spot +1 more

RECRUITING

Functional Study to Indentify Genetic Etiology of Rare Diseases - ORIGIN

NCT05499091

Rare Diseases Genetic Disease

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The immediate goal of this research is to create a natural history database to collect information from individuals who have a rare GSD. A repository of clinical, laboratory, and biochemical information on individuals with a rare GSD will allow a more definitive description of the different subtypes to be developed, which will permit development of treatment strategies in the future.

Duke will be the only site where this study takes place. However, since these are rare disorders, participants who receive care at other institutions will be included. The investigators will collect retrospective data from patient charts on diagnosed individuals, as far back as necessary to capture the clinical course of their disorder. Prospective data collected from patient charts after enrollment will be captured as well. Participant's medical records will be continually reviewed for the duration of the study.

Data will be collected from medical records and will only pertain to clinically relevant information, including, but not limited to: demographic and diagnostic information, tissue biopsy results, medical and family history, review of systems, imaging studies, results of liver, muscle, and nerve function testing, and urine and blood laboratory results.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glycogen Storage Disease GSD Type 0A GSD Type 0B GSD VII Tarui Disease GSD X GSD XII GSD XIII GSD XV PGBM2 PRKAG2 Danon Disease Polyglucosan Body Myopathy Type 1 Polyglucosan Body Myopathy Type 2 RBCK1 Deficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Rare GSD (Glycogen Storage Disease)

individuals with confirmed diagnosis of rare glycogen storage disease including but not limited to, GSD types 0a, 0b, VII, X, XII, XIII, XV, PRKAG2 syndrome and Danon disease

No intervention

Intervention Type OTHER

Observational. Natural history study.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

Observational. Natural history study.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of a rare GSD, including 0a, 0b, VII, X, XII, XIII, XV, PRKAG2 syndrome or Danon disease

* Two variants in the gene associated with the specific GSD type (for autosomal recessive diseases)
* One variant in the gene associated with the specific GSD type (for autosomal dominant or X-linked diseases)
* Deficient enzyme activity in liver, muscle, skin fibroblast or other tissue
* One variant in causative gene with evidence of disease, per a clinician
* Histology as confirmed by a clinician
* Able to provide informed consent for self (adults) or affected individual (minor or adults with a legally authorized representative)
* Able to provide consent for release of medical records
* Pregnant women with a diagnosis of a rare GSD will be included